anti-SARS-CoV (aa118-127) TCR, pCDTCR1(TCR-L103Z)
The vector of anti-SARS-CoV T cell receptor (TCR) is constructed for the engineering of T cell to target SARS-CoV. The T cells are genetically modified through transduction with a retroviral vector expressing SARS-CoV-specific T cell receptor. And the vector product was designed for the treatment of SARS-CoV.
API4; EPR-1; BIRC5; TCR; T cell receptor; transgenic TCR; antigen-specific T cell receptors; Engineering T-cell receptors; recombinant t cell receptors; specific t cell receptor; modified t cell receptor; retroviral vector; cancer
The SARS-CoV coronavirus, sometimes shortened to SARS-CoV, is the virus that causes severe acute respiratory syndrome (SARS-CoV). On April 16, 2003, following the outbreak of SARS-CoV in Asia and secondary cases elsewhere in the world, the World Health Organization (WHO) issued a press release stating that the coronavirus identified by a number of laboratories was the official cause of SARS-CoV.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.